Franken-algorithms: the deadly consequences of unpredictable code
By Andrew Smith,
The Guardian
| 08. 30. 2018
The 18th of March 2018, was the day tech insiders had been dreading. That night, a new moon added almost no light to a poorly lit four-lane road in Tempe, Arizona, as a specially adapted Uber Volvo XC90 detected an object ahead. Part of the modern gold rush to develop self-driving vehicles, the SUV had been driving autonomously, with no input from its human backup driver, for 19 minutes. An array of radar and light-emitting lidar sensors allowed onboard algorithms to calculate that, given their host vehicle’s steady speed of 43mph, the object was six seconds away – assuming it remained stationary. But objects in roads seldom remain stationary, so more algorithms crawled a database of recognizable mechanical and biological entities, searching for a fit from which this one’s likely behavior could be inferred.
At first the computer drew a blank; seconds later, it decided it was dealing with another car, expecting it to drive away and require no special action. Only at the last second was a clear identification found – a woman with a bike, shopping bags...
Related Articles
Not the species, certainly, but the Institute of that name, which was founded by transhumanist philosopher Nick Bostrom in 2005 as a research group at Oxford University. According to a recently posted Final Report, its goal was “to pursue the big questions in a transdisciplinary way” by pulling together “researchers from disciplines such as philosophy, computer science, mathematics, and economics.” This evolved before long into the study and promotion of “effective altruism” and “longtermism” as...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...